These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9167006)

  • 21. IC51 Japanese encephalitis vaccine.
    Kollaritsch H; Paulke-Korinek M; Dubischar-Kastner K
    Expert Opin Biol Ther; 2009 Jul; 9(7):921-31. PubMed ID: 19527110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intradermal boosting of Japanese encephalitis vaccination.
    Kitchener S; Baade L; Brennan L; Nasveld P
    J Travel Med; 2004; 11(3):182-3. PubMed ID: 15710061
    [No Abstract]   [Full Text] [Related]  

  • 23. Control of Japanese encephalitis--within our grasp?
    Solomon T
    N Engl J Med; 2006 Aug; 355(9):869-71. PubMed ID: 16943399
    [No Abstract]   [Full Text] [Related]  

  • 24. Development of dengue vaccines: an overview.
    Kanesa-thasan N
    Indian Pediatr; 1998 Feb; 35(2):97-100. PubMed ID: 9707850
    [No Abstract]   [Full Text] [Related]  

  • 25. A new inactivated Japanese encephalitis vaccine for adult travelers.
    Toovey S
    Travel Med Infect Dis; 2009 Sep; 7(5):301-4. PubMed ID: 19747666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new Japanese encephalitis vaccine (Ixiaro).
    Med Lett Drugs Ther; 2009 Aug; 51(1319):66-7. PubMed ID: 19696707
    [No Abstract]   [Full Text] [Related]  

  • 27. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
    Konishi E; Yamaoka M; Kurane I; Mason PW
    Virology; 2000 Mar; 268(1):49-55. PubMed ID: 10683326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dengue and other emerging flaviviruses.
    Solomon T; Mallewa M
    J Infect; 2001 Feb; 42(2):104-15. PubMed ID: 11531316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
    Yang SE; Pan MJ; Tseng HF; Liau MY
    Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, 1-2 June 2006.
    Ferguson M; Kurane I; Wimalaratne O; Shin J; Wood D;
    Vaccine; 2007 Jul; 25(29):5233-43. PubMed ID: 17590244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Japanese encephalitis vaccine--its preparation, effect and evaluation].
    Kawakita Y
    Shinkei Kenkyu No Shimpo; 1967 Aug; 11(2):399-409. PubMed ID: 4296457
    [No Abstract]   [Full Text] [Related]  

  • 32. Dengue and dengue vaccines.
    Edelman R
    J Infect Dis; 2005 Mar; 191(5):650-3. PubMed ID: 15688277
    [No Abstract]   [Full Text] [Related]  

  • 33. [Vaccination against Japanese encephalitis in not justified].
    Niklasson P
    Lakartidningen; 1988 Nov; 85(45):3815. PubMed ID: 2846974
    [No Abstract]   [Full Text] [Related]  

  • 34. An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model.
    Robert Putnak J; Coller BA; Voss G; Vaughn DW; Clements D; Peters I; Bignami G; Houng HS; Chen RC; Barvir DA; Seriwatana J; Cayphas S; Garçon N; Gheysen D; Kanesa-Thasan N; McDonell M; Humphreys T; Eckels KH; Prieels JP; Innis BL
    Vaccine; 2005 Aug; 23(35):4442-52. PubMed ID: 16005749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis.
    Lyons A; Kanesa-thasan N; Kuschner RA; Eckels KH; Putnak R; Sun W; Burge R; Towle AC; Wilson P; Tauber E; Vaughn DW
    Vaccine; 2007 Apr; 25(17):3445-53. PubMed ID: 17241714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody responses to an immunodominant nonstructural 1 synthetic peptide in patients with dengue fever and dengue hemorrhagic fever.
    Huang JH; Wey JJ; Sun YC; Chin C; Chien LJ; Wu YC
    J Med Virol; 1999 Jan; 57(1):1-8. PubMed ID: 9890415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Should travelers to Vietnam be vaccinated against japanese encephalitis?].
    Queuche F; Morillon M
    Med Trop (Mars); 1995; 55(1):102-3. PubMed ID: 7637595
    [No Abstract]   [Full Text] [Related]  

  • 38. [Japanese encephalitis].
    Jouan A
    Med Trop (Mars); 1994; 54(4):297-300. PubMed ID: 7746118
    [No Abstract]   [Full Text] [Related]  

  • 39. [Advances in the development of a vaccine against dengue].
    Guzmán MG
    Acta Cient Venez; 1998; 49 Suppl 1():38-45. PubMed ID: 10030053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines--report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies.
    Ferguson M; Johnes S; Li L; Heath A; Barrett A
    Biologicals; 2008 Mar; 36(2):111-6. PubMed ID: 17892945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.